Effects of s-ketamine and midazolam on respiratory variability: A randomized controlled pilot trial
PLOS One · 2025
DOI: 10.1371/journal.pone.0331358 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2025. Verfasst von Oscar F C van den Bosch und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Amsterdam UMC location Vrije Universiteit, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Ketamine, Midazolam, Respiratory Rate, Hypnotics and Sedatives. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Arthritis Association, NWO Stevin grant.
Abstract (Originalsprache)
S-ketamine and midazolam are frequently used to provide sedation while maintaining spontaneous respiration. However, the effects of these agents on respiratory variability, which reflects the adaptability of the respiratory system, have not been thoroughly explored. We evaluated these effects in a randomized controlled pilot trial. This study was conducted as part of a randomized controlled trial originally designed to assess the effects of s-ketamine conditioning on pain sensitivity in patients with fibromyalgia syndrome. Participants were randomly assigned to receive an infusion of either s-ketamine (0.3 mg kg -1 h -1 ), midazolam (0.05 mg kg -1 h -1 ), or saline in a blinded fashion. Mean respiratory rate, variability of respiratory rate (VRR), and variability of tidal volume (VTV) were measured continuously and non-invasively with a bio-impedance method. Changes during drug infusion were compared in a linear mixed model to assess the effects of s-ketamine and midazolam compared to saline. Data were analyzed for 57 experiments in 28 participants. Their median baseline variabilities of respiratory rate and tidal volume were 0.19 (IQR: 0.16–0.25) and 0.23 (0.19–0.34), respectively. While mean respiratory rate was not affected, midazolam resulted in a significant decrease in both VRR (ß = −0.071, 95% CI: −0.120 to −0.021) and VTV (ß = −0.117, 95% CI: −0.170 to −0.062). In contrast, s-ketamine appeared to produce a smaller decrease in VTV (ß = −0.062, 95% CI: −0.118 to −0.003) with VRR remaining unaffected (ß = −0.036, 95% CI: −0.092 to 0.019). In conclusion, our study demonstrates that midazolam reduces respiratory variability, potentially impairing the adaptability of the respiratory system. In contrast, s-ketamine largely preserved respiratory variability, suggesting it may be a safer alternative for sedation in patients with impaired spontaneous breathing. Further studies are needed to assess the clinical implications of these observations in patients undergoing sedation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Amsterdam UMC location Vrije Universiteit, Amsterdam, the Netherlands.
- Institute of Psychology, Leiden University, Leiden, the Netherlands.
ORCID-Profile: Oscar F C van den Bosch, Ricardo Alvarez-Jimenez, Henriët van Middendorp
Förderung
- Dutch Arthritis Association
- NWO Stevin grant
Zitieren
APA
van den Bosch, O. F. C., van Lennep, J. P. A., Alvarez-Jimenez, R., van Middendorp, H., Evers, A. W. M., Steegers, M. A. H., Schober, P., & Loer, S. A. (2025). Effects of s-ketamine and midazolam on respiratory variability: A randomized controlled pilot trial. PLOS One. https://doi.org/10.1371/journal.pone.0331358
Vancouver
van den Bosch OFC, van Lennep JPA, Alvarez-Jimenez R, van Middendorp H, Evers AWM, Steegers MAH, et al. Effects of s-ketamine and midazolam on respiratory variability: A randomized controlled pilot trial. PLOS One. 2025. doi:10.1371/journal.pone.0331358
BibTeX
@article{vandenBosch2025,
author = {van den Bosch, Oscar F C and van Lennep, Johan P A and Alvarez-Jimenez, Ricardo and van Middendorp, Henriët and Evers, Andrea W M and Steegers, Monique A H and Schober, Patrick and Loer, Stephan A},
title = {Effects of s-ketamine and midazolam on respiratory variability: A randomized controlled pilot trial},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0331358}
}
EUVIMED